Cellectar biosciences and spectronrx partner to manufacture novel phospholipid radioconjugate for the treatment of cancer

Cellectar broadens global manufacturing network in preparation for potential commercialization of iopofosine i 131 in 2025 cellectar broadens global manufacturing network in preparation for potential commercialization of iopofosine i 131 in 2025

CLRB Ratings Summary

CLRB Quant Ranking